News

Here’s a look at the life of renowned theoretical physicist, cosmologist, astronomer and mathematician, Stephen ...
Clene is continuing to work with U.S. regulators on its plans to seek accelerated approval of CNM-Au8 for the treatment of ...
Australia-based biotech Neurizon Therapeutics (OTCPK:PAAFF) has inked an exclusive global licensing agreement with Elanco ...
Exclusive Global Rights: Neurizon is granted exclusive global rights to Elanco’s data package and related intellectual property for monepantel to develop and commercialise NUZ-001 and its related ...
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased ...
Researchers propose new royalty-based investment model to bridge the 'valley of death' and accelerate drug developmentCambridge, Mass., Jul ...
A team of researchers from the MIT Sloan School of Management , the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH ...
A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...
A new brain-computer interface lets people with paralysis speak in real-time using their brain signals. It recreates their ...
Culture and resources shape physician attitudesA new study reveals striking international differences in how doctors approach ...
ALS is a slow progressing disease that doesn’t show symptoms right away. Dropping things often can be an early sign.
Unlike previous systems that convert brain signals into text, this BCI synthesizes actual speech almost instantaneously. The effect is a digital recreation of the vocal tract, ...